| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| 04/30/2026 | ±2.0% | +0.5% | over-priced |
| 02/17/2026 | ±3.7% | -0.2% | over-priced |
| 10/30/2025 | ±2.4% | +0.2% | over-priced |
| 07/31/2025 | ±1.9% | -1.3% | over-priced |
| 05/01/2025 | ±1.7% | +1.7% | under-priced |
| 02/18/2025 | ±1.9% | +0.3% | over-priced |
| 10/31/2024 | ±1.6% | -3.1% | under-priced |
| 07/31/2024 | ±2.5% | -1.9% | over-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $0.57 | $426M | $190M |
| Q4 FY2025 | — | $433M | $223M |
| Q3 FY2025 | $0.12 | $432M | $40M |
| Q2 FY2025 | $0.11 | $425M | $38M |
UDR (UDR) reports imminently, with the next report estimated for 10/27/2026. Across the last 8 reports, options priced an average ±2.2% earnings move while the stock actually moved 1.2% on average — the market has systematically over-priced UDR's earnings risk. Fundamentals into the print: EPS up 147.8% year-over-year, revenue up 0.9%. QuantLogix's live 5-factor engine currently reads UDR as a underweight at 29/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →